The paper reviews developments in the EU competition practice approach to “reverse payment agreements”. These are settlements that involve a payment (in direct or indirect form) flowing in a direction that intuitively appears “reverse”, as money is paid by the patent holder (the originator) to the alleged infringer – a generic firm.

Parcu, P.L., Rossi, M.A. (2011). Reverse Payment Settlements in the Pharmaceutical Sector: A European Perspective. EUROPEAN JOURNAL OF RISK REGULATION, 2, 260-262.

Reverse Payment Settlements in the Pharmaceutical Sector: A European Perspective

ROSSI, MARIA ALESSANDRA
2011-01-01

Abstract

The paper reviews developments in the EU competition practice approach to “reverse payment agreements”. These are settlements that involve a payment (in direct or indirect form) flowing in a direction that intuitively appears “reverse”, as money is paid by the patent holder (the originator) to the alleged infringer – a generic firm.
2011
Parcu, P.L., Rossi, M.A. (2011). Reverse Payment Settlements in the Pharmaceutical Sector: A European Perspective. EUROPEAN JOURNAL OF RISK REGULATION, 2, 260-262.
File in questo prodotto:
File Dimensione Formato  
1_pub_su_rivista.pdf

non disponibili

Tipologia: Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 84.08 kB
Formato Adobe PDF
84.08 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/36981
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo